Aytu Biopharma (AYTU) Other Non Operating Income (2015 - 2026)

Aytu Biopharma (AYTU) has 12 years of Other Non Operating Income data on file, last reported at $149000.0 in Q1 2026.

• On a quarterly basis, Other Non Operating Income rose 313.89% year-over-year to $149000.0 in Q1 2026; TTM through Mar 2026 was $5.4 million, a 120.81% increase from a year earlier, with the FY2024 full-year figure at -$594000.0, down 422.83% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $149000.0, down from $190000.0 in the prior quarter.
• Over the last five years, Other Non Operating Income for AYTU reached as high as $3.8 million in Q3 2025 and fell as low as -$5.9 million in Q3 2023.
• Historically, Other Non Operating Income has averaged $645823.5 across 5 years, with a median of $149000.0 in 2026.
• Across the five-year window, Other Non Operating Income tumbled 377.82% in 2022 and soared 36857.14% in 2023, its largest moves.
• Year by year, Other Non Operating Income stood at -$1.2 million in 2022, then surged by 107.82% to $96000.0 in 2023, then surged by 45.83% to $140000.0 in 2024, then soared by 35.71% to $190000.0 in 2025, then dropped by 21.58% to $149000.0 in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $149000.0 in Q1 2026, $190000.0 in Q4 2025, and $3.8 million in Q3 2025.